Free Trial

Vertex Pharmaceuticals (VRTX) Insider Trading & Ownership

-3.39 (-0.69%)
(As of 07/12/2024 ET)

Vertex Pharmaceuticals (NASDAQ:VRTX) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
$47.57 M
Get VRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vertex Pharmaceuticals stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VRTX Insider Buying and Selling by Quarter

Vertex Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/10/2024Carmen BozicCMOSell2,280$487.34$1,111,135.20  
6/26/2024Carmen BozicCMOSell2,280$471.72$1,075,521.60  
6/12/2024Carmen BozicCMOSell2,280$478.00$1,089,840.00  
6/12/2024Edward Morrow Atkinson IIIEVPSell7,288$478.00$3,483,664.00  
5/30/2024Ourania TatsisEVPSell2,350$439.11$1,031,908.50  
5/29/2024Carmen BozicCMOSell2,280$445.56$1,015,876.80  
5/28/2024Charles F Wagner JrCFOSell3,250$454.79$1,478,067.50  
5/24/2024Reshma KewalramaniCEOSell1,565$457.00$715,205.00  
5/22/2024Bruce I SachsDirectorSell7,073$448.00$3,168,704.00  
5/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$401.08$1,001 - $15,000
2/26/2024Ourania TatsisEVPSell354$425.70$150,697.80  
2/20/2024Ourania TatsisEVPSell480$420.79$201,979.20  
2/12/2024Amit SachdevEVPSell3,222$420.24$1,354,013.28  
2/12/2024Jeffrey M LeidenChairmanSell2,656$419.51$1,114,218.56  
2/12/2024Kristen AmbroseCAOSell1,374$420.24$577,409.76  
2/12/2024Stuart A ArbuckleCOOSell4,295$420.24$1,804,930.80  
1/8/2024Jeffrey M LeidenChairmanSell6,648$419.07$2,785,977.36  
11/6/2023Bruce I SachsDirectorSell11,250$385.00$4,331,250.00  
10/31/2023Carmen BozicCMOSell5,651$355.92$2,011,303.92  
10/24/2023Greg StantonU.S. Congress Member (D-AZ)Sell$369.38$1,001 - $15,000
10/17/2023Carmen BozicCMOSell5,651$373.25$2,109,235.75  
10/17/2023Sangeeta N BhatiaDirectorSell243$375.00$91,125.00  
10/16/2023Jeffrey M LeidenChairmanSell12,962$374.00$4,847,788.00  
10/6/2023Sangeeta N BhatiaDirectorSell242$360.00$87,120.00  
10/3/2023Carmen BozicCMOSell5,651$345.28$1,951,177.28  
10/2/2023Jonathan BillerEVPSell610$346.76$211,523.60  
9/19/2023Carmen BozicCMOSell5,651$351.00$1,983,501.00  
8/23/2023Ourania TatsisEVPSell2,500$355.00$887,500.00  
8/9/2023David AltshulerEVPSell63$345.51$21,767.13  
8/9/2023Sangeeta N BhatiaDirectorSell242$345.51$83,613.42  
7/17/2023Bruce I SachsDirectorSell11,250$356.75$4,013,437.50  
7/17/2023Reshma KewalramaniCEOSell7,828$355.00$2,778,940.00  
(Data available from 1/1/2013 forward)

VRTX Insider Trading Activity - Frequently Asked Questions

What percentage of Vertex Pharmaceuticals stock is owned by insiders?

0.20% of Vertex Pharmaceuticals stock is owned by insiders. Learn more on VRTX's insider holdings.

Which Vertex Pharmaceuticals insiders have been selling company stock?

The following insiders have sold VRTX shares in the last 24 months: Amit Sachdev ($1,354,013.28), Bastiano Sanna ($5,714,250.25), Bruce I Sachs ($18,472,740.50), Carmen Bozic ($12,347,591.55), Charles F Wagner Jr ($3,998,815.80), David Altshuler ($5,972,384.50), Edward Morrow Atkinson III ($3,483,664.00), Jeffrey M Leiden ($48,869,051.68), Jonathan Biller ($211,523.60), Joy Liu ($1,422,513.30), Kristen Ambrose ($1,019,800.59), Lloyd Carney ($865,404.00), Ourania Tatsis ($2,874,633.67), Reshma Kewalramani ($11,335,219.70), Sangeeta N Bhatia ($1,011,458.62), Stuart A Arbuckle ($16,898,907.58), and Yuchun Lee ($2,518,290.59).

How much insider selling is happening at Vertex Pharmaceuticals?

Insiders have sold a total of 423,053 Vertex Pharmaceuticals shares in the last 24 months for a total of $138,370,263.21 sold.

Which members of congress are trading Vertex Pharmaceuticals?

Tommy Tuberville (R-AL) and Greg Stanton (D-AZ) have sold shares of Vertex Pharmaceuticals in the last year totaling $16,000.

This page (NASDAQ:VRTX) was last updated on 7/14/2024 by Staff

From Our Partners